Skip to content

EXTENSE PHARMA

Open bankruptcy
Private limited company (pre-2019)founded 2009KBO/BCE: BE 0821.673.538

A bankruptcy procedure is open for EXTENSE PHARMA according to publications in the Belgian State Gazette; curator: KARL STEINIER.

Summary

The file additionally contains 6 judicial reorganisation notices and 1 administrative flag. The 2021 annual accounts show negative equity (-€437,008) and a net result of -€120,752.

EXTENSE PHARMAOpen bankruptcy

Are you a creditor?

Open bankruptcy Source: Belgian Official Gazette

If this company owes you money, you are not paid automatically: you file your claim yourself, within the deadline the judgment sets.

The procedure

Court
Enterprise Court of Liège, Namur division
Declared bankrupt
15 December 2022
Supervising judge
Renato Sanchioni
Official Gazette
21-12-2022 (pdf) ↗search the document for 2022/147629

Deadlines

Appeal or third-party opposition until
passed on 5 January 2023Fifteen days after the publication in the Official Gazette.art. XX.108 CEL
File the claim in RegSol until
passed on 14 January 2023art. XX.104 and XX.155 CEL
First verification report
passed on 25 January 2023Goods that belong to you, such as those delivered under retention of title, are reclaimed before this day.art. XX.104 and XX.194 CEL
Late claim until
passed on 15 December 2023Late, you share only in what has not been paid out yet, and the costs are yours.art. XX.165 CEL

Curator

What to do now

  1. Do not deliver on credit any more without an agreement with the curator.
  2. Gather your documents: invoices, purchase orders, contract, delivery notes and reminders.
  3. File your proof of claim in RegSol (regsol.be), yourself with eID or itsme, or through your lawyer. State principal, interest and costs separately, and any preferential right you hold.
  4. Delivered under retention of title? Reclaim your goods before the first report on the verification of claims.
  5. Ask your accountant about the VAT on the unpaid invoices: in a bankruptcy it can be recovered under conditions.
  6. Follow the file in RegSol: the verification report (admitted or disputed) and the curator's reports appear there.

The deadlines above come from the publication of the judgment. Check them in RegSol before you file anything; a passed deadline no longer applies.

File a claim in RegSol ↗ Watch Follow this bankruptcy: you are alerted when it is closed or reversed.

General information, not legal advice. If in doubt, the curator, your lawyer or your accountant can help.Creditor guide for this company

Embed in an article

Writing about this bankruptcy? Put the card of EXTENSE PHARMA in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.

Preview
The preview appears here.
  • Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
  • Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
  • Where scripts do not run (a newsletter, a feed reader) a plain link remains.

Signals

Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Register: open bankruptcy
The KBO register records the legal situation: open bankruptcy. This is today's state according to the register itself; the register carries no start date.
KBO · legal situation
raises risk · Open bankruptcy
Active bankruptcy procedure in the Belgisch Staatsblad. Claims are handled by the appointed curator.
Belgian State Gazette
neutral · Filed after the deadline
The financial year that closed on 31-12-2021 was due by 31-07-2022 and was filed on 24-10-2022, 85 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
not filed
2023
not filed
2022
not filed
2021
85 d late
2020
450 d late
2019
447 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 327 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

raises risk · Administrative warnings in the KBO publications
1 publication by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or its withdrawal.
KBO publications
Publications
Address struck

History

EXTENSE PHARMA was incorporated on 17 December 2009.1 Total assets fell from EUR 1.4 million in 2018 to EUR 394,215 in 2021.2 On 15 December 2022 the company was declared bankrupt.3

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2021
  3. 3Belgian State Gazette, 21-12-2022

Go further with this company

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2021, micro schema

Turnover
€1.4m
EBIT margin
-10.0%
Net result
-€120,752▼ 94.8%
2020 · -€61,973
Working capital
-€413,263▼ 48.0%
2020 · -€279,279
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line2018201920202021
Turnover€1.4m-
Operating result-€136,831--€350,936▼ 156%-€40,318▲ 88.5%-€100,466▼ 149%
Net result-€153,129--€379,703▼ 148%-€61,973below the sector's middle half▲ 83.7%-€120,752below the sector's middle half▼ 94.8%
EBIT margin-10.0%-
Equity€125,420--€254,283-€316,256below the sector's middle half▼ 24.4%-€437,008below the sector's middle half▼ 38.2%
Total assets€1.4m-€846,193▼ 40.6%€456,010above the sector's middle half▼ 46.1%€394,215within the sector's middle half▼ 13.6%
Debt€1.3m-€1.1m▼ 15.3%€772,266▼ 29.8%€831,224▲ 7.6%
Working capital-€150,481--€206,746▼ 37.4%-€279,279▼ 35.1%-€413,263▼ 48.0%
Solvency8.8%--30.1%▼ 38.9pp-69.4%below the sector's middle half▼ 39.3pp-110.9%below the sector's middle half▼ 41.5pp
above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€400,000-€300,000-€200,000-€100,000€0Operating result 2018: -€136,831-€136,831Net result 2018: -€153,129-€153,129Operating result 2019: -€350,936-€350,936Net result 2019: -€379,703-€379,703Operating result 2020: -€40,318-€40,318Net result 2020: -€61,973-€61,973Operating result 2021: -€100,466-€100,466Net result 2021: -€120,752-€120,7522018201920202021-€400,000-€300,000-€200,000-€100,000€0Operating result 2019: -€350,936-€351,000Net result 2019: -€379,703-€380,000Operating result 2020: -€40,318-€40,300Net result 2020: -€61,973-€62,000Operating result 2021: -€100,466-€100,000Net result 2021: -€120,752-€121,000201920202021
The operating result stays negative: a loss of €100,466 in 2021 against €40,318 in 2020; the loss grows.
Balance-sheet composition
2021 in colour, 2020 as the grey bar beneath
Assets €394,215
Fixed assets €91,879 ▼ 38.5%
Current assets €302,337 ▼ 1.4%
Key figures and ratios
2021 value · change against 2020
EBITDA
-€43,005▼
2020 · €18,061
Cash flow
-€63,292▼
2020 · -€3,595
Current ratio
0.42▼
2020 · 0.52
Quick ratio
0.18▼
2020 · 0.23
Debt to equity
-1.90▲
2020 · -2.44
ROA
-30.6%▼
2020 · -13.6%
Interest coverage
-2.12▼
2020 · 0.87
Debt ≤ 1 year
€715,600▲
2020 · €585,950
Debt > 1 year
€115,624▼
2020 · €186,316
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2021 against 2020 · 45 lines
Balance sheet Code20202021
Assets
Total assets20/58€456,010€394,215▼
Fixed assets21/28€149,339€91,879▼
Intangible fixed assets21€142,661€85,201▼
Tangible fixed assets22/27€0-
Furniture and vehicles24€0-
Financial fixed assets28€6,678€6,678=
Current assets29/58€306,671€302,337▼
Stocks and contracts in progress3€171,000€171,000=
Stocks30/36€171,000€171,000=
Amounts receivable within one year40/41€135,069€131,254▼
Other amounts receivable41€135,069€131,254▼
Cash at bank and in hand54/58€603€83▼
Equity and liabilities
Total equity and liabilities10/49€456,010€394,215▼
Equity10/15-€316,256-€437,008▼
Contributions10/11€168,600€168,600=
Reserves13€20,363€20,363=
Non-distributable reserves130/1€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860=
Distributable reserves133€18,503€18,503=
Profit (loss) carried forward14-€505,218-€625,971▼
Amounts payable17/49€772,266€831,224▲
Amounts payable after more than one year17€186,316€115,624▼
Financial debts170/4€186,316€115,624▼
Amounts payable within one year42/48€585,950€715,600▲
Current portion of amounts payable after more than one year42€93,404€164,707▲
Financial debts43€101,073€187,909▲
Credit institutions430/8€101,073€187,909▲
Trade debts44€152,515€116,803▼
Suppliers440/4€152,515€116,803▼
Other amounts payable47/48€238,958€246,181▲
Income statement Code20202021
Remuneration, social security and pensions62€260-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€58,378€57,460▼
Other operating charges640/8€1,331€50▼
Gross operating margin9900€19,652-€42,955▼
Operating profit (loss)9901-€40,318-€100,466▼
Financial income75/76B€1-
Recurring financial income75€1-
Financial charges65/66B€20,861€20,287▼
Recurring financial charges65€20,861€20,287▼
Profit (loss) for the period before taxes9903-€61,178-€120,752▼
Income taxes67/77€795-
Profit (loss) for the period9904-€61,973-€120,752▼
Profit (loss) for the period to be appropriated9905-€61,973-€120,752▼
Appropriation of the result
Profit (loss) to be appropriated9906-€505,218-€625,971▼
Profit (loss) brought forward from the previous period14P-€443,246-€505,218▼

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2018201920202021Change
Turnover70€1.4m----
Remuneration, social security and pensions62--€260--
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€44,696€68,184€58,378€57,460▼ 1.6%
Other operating charges640/8--€1,331€50▼ 96.2%
Gross operating margin9900-€88,269-€280,585€19,652-€42,955▼ 319%
Operating profit (loss)9901-€136,831-€350,936-€40,318-€100,466▼ 149%
Financial income75/76B--€1--
Recurring financial income75€1€1€1--
Financial charges65/66B--€20,861€20,287▼ 2.8%
Recurring financial charges65€16,293€27,815€20,861€20,287▼ 2.8%
Profit (loss) for the period before taxes9903-€153,123-€378,750-€61,178-€120,752▼ 97.4%
Income taxes67/77€6€953€795--
Profit (loss) for the period9904-€153,129-€379,703-€61,973-€120,752▼ 94.8%
Profit (loss) for the period to be appropriated9905-€153,129-€379,703-€61,973-€120,752▼ 94.8%
Line2018201920202021Change
Assets
Total assets20/58€1.4m€846,193€456,010€394,215▼ 13.6%
Fixed assets21/28€275,901€207,717€149,339€91,879▼ 38.5%
Intangible fixed assets21€268,762€200,942€142,661€85,201▼ 40.3%
Tangible fixed assets22/27€461€98€0--
Furniture and vehicles24--€0--
Financial fixed assets28€6,678€6,678€6,678€6,678=
Current assets29/58€1.1m€638,475€306,671€302,337▼ 1.4%
Stocks and contracts in progress3€186,000€171,000€171,000€171,000=
Stocks30/36--€171,000€171,000=
Amounts receivable within one year40/41€905,586€467,394€135,069€131,254▼ 2.8%
Other amounts receivable41--€135,069€131,254▼ 2.8%
Cash at bank and in hand54/58€56,879€82€603€83▼ 86.3%
Equity and liabilities
Total equity and liabilities10/49€1.4m€846,193€456,010€394,215▼ 13.6%
Equity10/15€125,420-€254,283-€316,256-€437,008▼ 38.2%
Contributions10/11€168,600-€168,600€168,600=
Reserves13€20,363€20,363€20,363€20,363=
Non-distributable reserves130/1--€1,860€1,860=
Reserves not available under the articles1311--€1,860€1,860=
Distributable reserves133--€18,503€18,503=
Profit (loss) carried forward14-€63,542-€443,246-€505,218-€625,971▼ 23.9%
Amounts payable17/49€1.3m€1.1m€772,266€831,224▲ 7.6%
Amounts payable after more than one year17-€255,254€186,316€115,624▼ 37.9%
Financial debts170/4--€186,316€115,624▼ 37.9%
Amounts payable within one year42/48€1.3m€845,221€585,950€715,600▲ 22.1%
Current portion of amounts payable after more than one year42--€93,404€164,707▲ 76.3%
Financial debts43--€101,073€187,909▲ 85.9%
Credit institutions430/8--€101,073€187,909▲ 85.9%
Trade debts44€417,237€415,537€152,515€116,803▼ 23.4%
Suppliers440/4--€152,515€116,803▼ 23.4%
Other amounts payable47/48--€238,958€246,181▲ 3.0%
Line2018201920202021Change
Profit (loss) for the period9904-€153,129-€379,703-€61,973-€120,752▼ 94.8%
+ Depreciation and write-downs630€44,696€68,184€58,378€57,460▼ 1.6%
Operating cash flow (approximation)-€108,432-€311,519-€3,595-€63,292▼ 1,661%
Investment in fixed assets (approximation)-€0€0€0-
Change in cash--€56,797€521-€520▼ 200%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
20-06
KBO administration Address struck
2022
21-12
Bankruptcy Opening
Tribunal de l’entreprise de Liège, division Namur · event 15-12-2022
25-11
Judicial reorganisation Extension
Tribunal de l’entreprise de Liège · amicable agreement · event 22-11-2022
03-11
Judicial reorganisation Opening
Tribunal de l’entreprise de Liège · amicable agreement · event 25-10-2022
24-10
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 85 days late
24-10
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 450 days late
07-01
Judicial reorganisation Plan homologation
Tribunal de l’entreprise du Brabant wallon · event 03-01-2022
2021
21-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 447 days late
19-10
Judicial reorganisation Extension
Tribunal de l’entreprise du Brabant wallon · collective agreement · event 11-10-2021
19-07
Judicial reorganisation Extension
Tribunal de l’entreprise du Brabant wallon · collective agreement · event 13-07-2021
22-03
Judicial reorganisation Extension
Tribunal de l’entreprise du Brabant wallon · collective agreement · event 15-03-2021
2019
31-12
Financial Weakest financial yearnet -€379,703
Net result drops to -€379,703, the lowest in the series.
Show earlier events
25-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
28-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 28 days late
2017
23-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 23 days late
2016
07-07
NBB filing Annual accounts filed
fiscal year 2015 · full schema
2015
31-08
NBB filing Annual accounts filed
fiscal year 2014 · full schema · 31 days late
2014
04-07
NBB filing Annual accounts filed
fiscal year 2013 · full schema
2013
04-07
NBB filing Annual accounts filed
fiscal year 2012 · full schema
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts

We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 2010
seat establishment The establishment unit on the map
Ground area
2,724 m²
Building footprint
348 m²
2 parcels, Wallonia. Linked by address, not a title deed.
1 establishment unit
Extense Pharma
Avenue Vendôme 1, 1380 LasneManufacture of food products
since 20102.183.994.590
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25055C0308/00C003 Wallonia 1,756 m² 1 · 250 m² -
25087C0509/00V002 Wallonia 967 m² 1 · 98 m² -
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Insolvency mandates

1 mandate
Role Name Tenure
Curator KARL STEINIER
RUE DES FAUCONS 61, 5004 BOUGE-
15-12-2022 → present

Similar companies · same sector, comparable size

Of 4,414 companies in sector 46180 we hold annual accounts for 1,887. 1,415 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company (pre-2019)
Founded17-12-2009
Fiscal year end31-12
Activities, NACEBEL 2025
46180Agents specialised in the wholesale of other particular products
10860Manufacture of food products
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.